IFNG and bacterial infectious disease: Interestingly, a recently published study found that activation‐induced downregulation of miR‐29a/b facilitated Ifng production in activated CD4+ T cells and natural killer (NK) cells to resist intracellular bacterial infection and that miR‐29a/b directly targeted Ifng [23].